-
By Joyce Hanson, AdvisorOne |
August 24, 2011
ByAllAccounts and Redtail Technology announced a partnership that will give advisors easier access to a client snapshot that combines client relationship management (CRM) software with clients’ account data.
-
By James J. Green, AdvisorOne |
August 19, 2011
Envestnet Chairman Jud Bergman says more acquisitions possible following $24 million deal for TAMP provider.
-
By James J. Green, AdvisorOne |
August 8, 2011
Envestnet–which has built on its TAMP legacy–will use cash to acquire BNP Paribas' U.S. TAMP provider
-
By Marlene Y. Satter, AdvisorOne |
July 12, 2011
A partnership between Envestnet and NyAllAccounts aims to streamline administrative tasks to help advisors grow client wealth.
-
By Marlene Y. Satter, AdvisorOne, Joyce Hanson, AdvisorOne |
May 2, 2011
As fund companies enter the second quarter of 2011, product deals have come from a diverse range of shops, including UBS in a deal with Wells Fargo, Envestnet in a strategic initiative with Vestmark and National Advisors Trust in partnerships with Advisors Asset Management and EPIC Advisors Inc.
-
By James J. Green, AdvisorOne |
April 20, 2011
Envestnet puts Brinker’s Crystal Strategy alternatives portfolio on its platform.
-
By James J. Green, AdvisorOne |
March 22, 2011
John Fitzpatrick, ex-Fidelity, and Sean Mullen, ex-Fortigent join Envestnet in sales, SMA consulting roles.
-
By Joyce Hanson, AdvisorOne |
January 24, 2011
Envestnet has aligned itself in favor of the SEC’s decision to proceed with a uniform fiduciary standard, says James Patrick of Advisor Managed Programs.
-
By James J. Green, AdvisorOne |
July 29, 2010
Ringing the bell to start the day of trading at the New York Stock Exchange on Thursday, July 29, Envestnet Inc. formally became a public company under the ticker ENV.
-
By Joyce Hanson, AdvisorOne |
May 21, 2010
Envestnet Inc., a Chicago-based investment technology provider, has filed for an initial public offering of common stock with the Securities and Exchange Commission (SEC) in hopes of reaping a $100 million cash infusion.